Skip to content

BIOGEM: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

BIOGEM

BE 0838.015.860
NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparations
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€16,446
2024 · -€12,734-€3,712
Equity
€37,130
2024 · -€66,424+€103,554
Cash
€6,611
2024 · €6,337+€274
Balance sheet total
€183,013
2024 · €195,541-€12,528

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€10,978

    down €10,978 (-37.8%), from €29,068 to €18,090

    of which Trade receivables: -€10,578

Equity and liabilities
  • Contributions +€120,000

    up €120,000 (+48.3%), from €248,600 to €368,600

  • Debts after one year -€120,000

    no longer reported in 2025 (was €120,000)

  • Profit (loss) carried forward -€16,446

    down €16,446 (-5.2%), from -€315,024 to -€331,470

  • Trade debts +€2,935

    up €2,935 (+13.9%), from €21,141 to €24,075

Income statement
  • Staff costs +€6,851

    up €6,851 (+7.9%), from €87,008 to €93,859

  • Depreciation -€3,238

    down €3,238 (-34.4%), from €9,409 to €6,171

  • Financial charges +€3,205

    up €3,205 (+1191.3%), from €269 to €3,474

    of which Non-recurring financial charges: +€3,000

  • Gross operating margin +€2,565

    up €2,565 (+3.0%), from €86,421 to €88,985

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€12,734
Gross operating margin +€2,565
Staff costs -€6,851
Depreciation +€3,238
Other operating charges +€550
Financial income -€10
Financial charges -€3,205
Result 2025 -€16,446

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€5,089
Investment -€5,231
Financing +€416
Cash 2024 €6,337
Net result for the year -€16,446
Depreciation +€6,171
Stocks and contracts +€1,257
Receivables within one year +€10,978
Deferred charges and accrued income -€373
Trade debts +€2,935
Tax, wage and social debts +€757
Other debts -€190
Investment in fixed assets (net) -€5,231
Debts after one year -€120,000
Short-term financial debts +€416
Contributions, distributions and other +€120,000
Cash 2025 €6,611
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €195,541 €183,013 -€12,528 -6.4%
Fixed assets 21/28 €130,217 €129,276 -€940 -0.7%
Intangible fixed assets 21 €99,280 €99,280 = 0.0%
Tangible fixed assets 22/27 €30,467 €29,527 -€940 -3.1%
Land and buildings 22 €3,300 €3,000 -€300 -9.1%
Plant, machinery and equipment 23 €8,187 €6,412 -€1,774 -21.7%
Furniture and vehicles 24 - €3,343 +€3,343
Other tangible fixed assets 26 €18,980 €16,772 -€2,209 -11.6%
Financial fixed assets 28 €469 €469 = 0.0%
Current assets 29/58 €65,324 €53,737 -€11,587 -17.7%
Stocks and contracts in progress 3 €26,933 €25,676 -€1,257 -4.7%
Stocks 30/36 €26,933 €25,676 -€1,257 -4.7%
Amounts receivable within one year 40/41 €29,068 €18,090 -€10,978 -37.8%
Trade receivables 40 €28,054 €17,476 -€10,578 -37.7%
Other amounts receivable 41 €1,013 €614 -€400 -39.4%
Cash at bank and in hand 54/58 €6,337 €6,611 +€274 +4.3%
Deferred charges and accrued income 490/1 €2,986 €3,360 +€373 +12.5%
Total equity and liabilities 10/49 €195,541 €183,013 -€12,528 -6.4%
Equity 10/15 -€66,424 €37,130 +€103,554
Contributions 10/11 €248,600 €368,600 +€120,000 +48.3%
Profit (loss) carried forward 14 -€315,024 -€331,470 -€16,446 -5.2%
Amounts payable 17/49 €261,965 €145,883 -€116,082 -44.3%
Amounts payable after more than one year 17 €120,000 - -€120,000
Financial debts 170/4 €120,000 - -€120,000
Amounts payable within one year 42/48 €141,965 €145,883 +€3,918 +2.8%
Financial debts 43 - €416 +€416
Credit institutions 430/8 - €416 +€416
Trade debts 44 €21,141 €24,075 +€2,935 +13.9%
Suppliers 440/4 €21,141 €24,075 +€2,935 +13.9%
Taxes, remuneration and social security 45 €5,906 €6,663 +€757 +12.8%
Taxes 450/3 €259 €1,690 +€1,431 +552.6%
Remuneration and social security 454/9 €5,647 €4,973 -€674 -11.9%
Other amounts payable 47/48 €114,918 €114,728 -€190 -0.2%
Remuneration, social security and pensions 62 €87,008 €93,859 +€6,851 +7.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €9,409 €6,171 -€3,238 -34.4%
Other operating charges 640/8 €2,479 €1,929 -€550 -22.2%
Gross operating margin 9900 €86,421 €88,985 +€2,565 +3.0%
Operating profit (loss) 9901 -€12,475 -€12,972 -€498 -4.0%
Financial income 75/76B €10 - -€10
Recurring financial income 75 €10 - -€10
Financial charges 65/66B €269 €3,474 +€3,205 +1191.3%
Recurring financial charges 65 €269 €474 +€205 +76.1%
Non-recurring financial charges 66B - €3,000 +€3,000
Profit (loss) for the period before taxes 9903 -€12,734 -€16,446 -€3,712 -29.1%
Profit (loss) for the period 9904 -€12,734 -€16,446 -€3,712 -29.1%
Profit (loss) for the period to be appropriated 9905 -€12,734 -€16,446 -€3,712 -29.1%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.